In recent months, both cities and states have moved to control how CBD is sold. Maine and New York City have moved to crack down on edible products containing CBD. New York’s health department confirmed to the New York Times that it has started ordering restaurants to stop selling CBD-laced food because it has not been “deemed safe as a food additive.”
Peltz will be granted options to purchase 19.9 million common shares in the company at C$10.34 ($7.74) a share. The options will vest over a four-year period on a quarterly basis, and the vesting may accelerate if the company meet certain goals, including the consummation of certain defined transactions and the share price being at least at C$31.02 and C$41.36 for a specified number of trading days.
The Spaniards brought hemp to the Americas and cultivated it in Chile starting about 1545. Similar attempts were made in Peru, Colombia, and Mexico, but only in Chile did the crop find success. In July 1605, Samuel Champlain reported the use of grass and hemp clothing by the (Wampanoag) people of Cape Cod and the (Nauset) people of Plymouth Bay told him they harvested hemp in their region where it grew wild to a height of 4 to 5 ft.  In May 1607, "hempe" was among the crops Gabriel Archer observed being cultivated by the natives at the main Powhatan village, where Richmond, Virginia is now situated; and in 1613, Samuell Argall reported wild hemp "better than that in England" growing along the shores of the upper Potomac. As early as 1619, the first Virginia House of Burgesses passed an Act requiring all planters in Virginia to sow "both English and Indian" hemp on their plantations. The Puritans are first known to have cultivated hemp in New England in 1645.
Hempworx provides Distributors with a variety of lead capture and product specific pages. You can enroll free below and take a tour of the distributor back office. I recently posted a new training call, “Your First 15-minutes as a Hempworx Distributor“. That training includes a 15-minute video of the back office and a discussion about Hempworx Leads and support that is exclusive to my team.
So true. Hearst and Rockefeller did not want Hemp or any form of Cannabis interfering with their lucrative paper, pharmaceutical and oil industries. Hemp is versatile and renewable. It can be used for food, medicine, fuel, paper, clothing, plastic, building materials; just about anything paper and oil is used for. These bastard wealthy people have done a disservice to all people and for the sake of lining their already copiously rich pockets. They and those like them are criminals of the worst order
HempWorx CBD is short for HempWorx CBD (cannabidiol) products featuring HempWorx CBD oil and 5 additional CBD products. The HempWorx CBD oil products are full spectrum meaning they consist of many parts of the hemp plant with a host of cannabinoids rather than isolated CBD alone. Our third party lab test results show you the breakdown of the cannabinoid profile and potency. Full spectrum CBD Oil combines the powerful active ingredients of the hemp plant to create an entourage effect which has been shown to be more effective in treating conditions such as chronic pain than isolated CBD only.
When you purchase a HempWorx Director pack for $199 U.S., you can mix and match your products! The Director pack gets you a CBD product for FREE! You can choose from any of our products: CBD Oil, THC FREE CBD Oil, Pain Cream, Skin Care, Coffee, Cream and Pet products too! 750mg is $20 more per bottle. All pricing is U.S. Buy Hempworx and change your health! 60 DAY MONEY BACK GUARANTEE!
The main difference between the two is in its chemical composition, specifically in tetrahydrocannabinol (THC). THC is the chemical responsible marijuana’s psychological effects.An average batch of marijuana contains anywhere from 5-20% THC content. Some premium marijuana can have up to 25-30% THC. Hemp, on the other hand, has a max THC level of 0.3%, essentially making it impossible to feel any psychoactive effect or get a “high”. This threshold is heavily regulated in other countries that have legalized hemp.Hemp also has high cannabidiol (CBD) content that acts as THC’s antagonist, essentially making the minimal amount of THC useless.
As part of the Agriculture Improvement Act of 2018, or the 2018 Farm Bill, signed by Republican President Donald Trump, the Hemp Farming Act of 2018 removed hemp (with less than 0.3% THC) from Schedule I, the most restrictive classification of controlled substances that are considered highly prone to abuse and not to have any medicinal benefit. This move allowed for cultivation and distribution of hemp as a legal agricultural product. Under the Hemp Farming Act, hemp cultivation is no longer limited to state departments and universities. In addition, the act allows hemp farmers rights to water, crop insurance, and federal agricultural grants, as well as legal access to national banking. Hemp may also be transported across state lines.
First, a little background. Industrial hemp was legal in the United States until Congress passed the Marihuana Tax Act in 1937. ("Some of our early presidents grew hemp," notes Sarah Lee Gossett Parrish, a cannabis industry attorney based in Oklahoma.) Nearly 80 years later, the 2014 Farm Bill took the position that states can regulate the production of hemp and, as a result, CBD. Then last year, President Trump signed a new Farm Bill that made it federally legal to grow hemp.
While it was originally believed that THC is a breakdown product of CBD, it is now known that both THC and CBD are actually metabolites of their decarboxylated acidic forms, THCa and CBDa. These acidic precursors are decarboxylated (essentially dried) by heat or extraction to produce THC and CBD; only then do they become psychoactive.The compound has medicinal benefits without the “high” that some patients do not desire. This makes CBD appealing to patients who are looking for an alternative to their current meds, which often have opiate-like effects.
CBD Oil is fast becoming the choice of consumers in the MMJ arena. It is clear that people want to be healthy and not high. Currently CBD is blowing past MMJ for the benefits of CBD without the high of THC. It clearly appears to be REPLACING MMJ and health professionals agree. Because CBD Oil is rich in CBD and has little to no THC (consider the new ZERO THC version), the benefits of CBD are prevalent, while the impairment of THC is nonexistent.
In Canada, the methodology used for analyses and sample collection for THC analysis of hemp plantings is standardized (at the Health Canada/Therapeutics Program/Hemp web site at www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/hemp.html, see “Industrial Hemp Technical Manual” for procedures on sampling plant materials and chemical procedures for determining THC levels). The regulations require that one of the dozen independent laboratories licensed for the purpose conduct the analyses and report the results to Health Canada. Sample collection is also normally carried out by an independent authorized firm. The Canadian system of monitoring THC content has rigidly limited hemp cultivation to cultivars that consistently develop THC levels below 0.3%.
Cannabis, especially the cannabinoid CBD, has also demonstrated its abilities as a powerful anti-convulsant. This property is what accounts for cannabis’ ability to reduce the severity and frequency of seizures, especially for people with epilepsy. In the United States, epilepsy is the most widely adopted qualifying condition for medical cannabis use, especially for children.
In 2019, the European Commission announced that CBD and other cannabinoids would be classified as "novel foods", meaning that CBD products would require authorization under the EU Novel Food Regulation stating: because "this product was not used as a food or food ingredient before 15 May 1997, before it may be placed on the market in the EU as a food or food ingredient, a safety assessment under the Novel Food Regulation is required." The recommendation – applying to CBD extracts, synthesized CBD, and all CBD products, including CBD oil – was scheduled for a final ruling by the European Commission in March 2019. If approved, manufacturers of CBD products would be required to conduct safety tests and prove safe consumption, indicating that CBD products would not be eligible for legal commerce until at least 2021.